Oral Cholera Vaccine

ApprovedVaccine

Takeda

Oral Cholera Vaccine is one of 13 biologic programs targeting Typhoid Fever. It is currently in Approved.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Typhoid FeverActive, not recruiting

Typhoid FeverApproved

Active, not recruiting

Competition

Competitive Landscape

24 competitors in Typhoid Fever

#DrugCompanyPhaseTrials

Zithromax

PPfizer's Upjohn has merged with Mylan to form Viatris Inc.

Approved

2 2

Merrem

BB. Braun Medical Inc.

Approved

2 3

Rocephin

CConrado Roberto Hoffmann Filho

Approved

1 4

Hepatitis a Vaccine

Sanofi

Approved

1 5

Cipro

Bayer

Phase 2

1 6

Levaquin

WWim Janssens

Phase 2

1 7

Gsk's Investigational Vaccine 692342

GSK

Phase 2

1 8

Oral Cholera Vaccine

Takeda

Approved

1 9

Typhoid Vi Vaccine

IInternational Vaccine Institute

Approved

1 10

TYPHIBEV

GSK

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Immune Response2 trials

Effect of Extended Dose Intervals on the Immune Response to Oral Cholera Vaccine

Completed·JJohns Hopkins Bloomberg School of Public Health·Phase 4·NCT03373669·120 enrolled

Immune Response to Systemic and Mucosal Antigenic Challenge in the Presence of Vedolizumab

Completed· Takeda logo

Takeda·Phase 1·NCT01981616·127 enrolled

Immunogenicity1 trial

Immunogenicity of Co-administered Oral Polio Vaccine and Oral Cholera Vaccine

Unknown status·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 3·NCT03581734·579 enrolled

Typhoid Fever1 trial

Immune Response Elicited by Concomitant Administration of Oral Typhoid Fever (Vivotif®) and Cholera (Dukoral®) Vaccines

Completed·HHelsinki University Central Hospital·Phase 4·NCT06104345·65 enrolled

Unspecified1 trial

Co-administration Study of OCV, TCV and MR

Unknown status·IInternational Centre for Diarrhoeal Disease Research, Bangladesh·Phase 3·NCT05771779·2,117 enrolled

Sources

References

[1]
ClinicalTrials.gov — 5 trial records for Oral Cholera Vaccine. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — Oral Cholera Vaccine compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for Oral Cholera Vaccine. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Takeda company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Vaccine[2]
Highest Phase: Approved[1]
Company: Takeda

Oral Cholera Vaccine

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Immune Response2 trials

Immunogenicity1 trial

Typhoid Fever1 trial

Unspecified1 trial

References

Drug Info

Quick Facts

Related News